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Abstract
Zika virus (ZIKV) is a health burden due to the severe neurological abnormalities that arise
after congenital infection. Although multiple experimental studies have linked ZIKV with neu-
ral birth defects, the scientific community has not been able to fully explain why Congenital
Zika Syndrome (CZS) was only apparent after the virus entered the Americas and why these
occurrences have an asymmetric geographic distribution. Here, we review the impact of
ZIKV infection on human populations by exploring evolutionary changes in the virus’ genome
as well as examining the diverse genetic and environmental cofactors of the human hosts.
Background
Although Zika virus (ZIKV) was first isolated in 1947 in Uganda [1] and has been circulat-
ing in human populations along West Africa and Asia since the mid-1950s, little attention
was devoted to it until the beginning of the 21st century [2–4]. Probably, the mildness of
its symptoms and the fact that it was geographically restricted resulted in ZIKV being a
neglected disease for most of its history. However, this started to change in 2013 when the
landing of ZIKV in French Polynesia was associated with increased rates of Guillain–
Barre syndrome, an autoimmune condition that affects the peripheral nervous system and
can be triggered by infections. In 2015, only two years after the Polynesian outbreak, an
unprecedented epidemic was registered in Brazil. There, ZIKV became an extraordinary
health burden due to the novel correlation between it and severe brain malformations in
newborns. Rapidly, several studies endorsed this causal relationship—between ZIKV and
brain development disorders [5–7]—with some authors stating that there was enough evi-
dence to consider it a new member of the teratogenic congenital infections of the Syphilis,
Toxoplasmosis, others, Rubella, Cytomegalovirus, and Herpes virus (STORCH) group
[8]. As cases accumulated, the term Congenital Zika Syndrome (CZS) was proposed,
which stands for a spectrum of different neuropathological conditions that emerge after
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ZIKV intrauterine transmission [9–11] (Table 1). Despite a notable increase in scientific
focus, which reached feverish heights after a World Health Organization emergency alert,
the path of CZS leaves some puzzling questions unsolved.
ZIKV is an RNA virus from the Flaviviridae family, which has an 11-kb genome encoding
seven nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) and three structural proteins
(C, prM, and E) [12]. From a phylogenetic point of view, there are two main lineages of ZIKV:
the African and the Asian lineage [4]. It is estimated that the Asian lineage entered the Ameri-
cas in 2013, where the ZIKV genome has experienced several mutations. The functional impli-
cations of these genomic changes are an active topic of study [13,14], while the rapid
geographic dispersion was attributed to the ubiquitous presence of its vector: the mosquitoes
of the genus Aedes [15,16]. Moreover, the finding that ZIKV is also sexually transmitted not
only expanded the transmission channel to hosts [17,18] but also broadened the geographic
reach to nontropical countries.
By the end of 2016, ZIKV infection had been reported in approximately 58 countries and
across all the main continents; a total of 23 countries reported cases of microcephaly and other
congenital anomalies potentially caused by ZIKV infection. Notably, 95% of all CZS cases in
2015 and 2016 were reported in Brazil, of which more than 75% were from the Northeast
region of Brazil (Fig 1) [19]. In other words, although ZIKV outbreaks were registered in simi-
lar proportions across many geographic areas, informed cases of CZS have been clustered,
indicating an asymmetric distribution among human populations [19,20]. This peculiarity
opened several questions: why does the symptom distribution of such a widely spread virus
vary so significantly by region and apparently also over time? Are there significant cofactors
that help to determine the observed pattern?
ZIKV evolution
One possible explanation for the sudden emergence of CZS is the proposition that the ZIKV
genome changed immediately before or upon entering the Americas. A recent work has
assessed this hypothesis. Yuan and colleagues [12] compared the neurovirulence of an ances-
tral Asian strain with a contemporary one isolated in the Americas. They found that
Table 1. Features commonly described in cases of CZS newborns.
Type of abnormality Description
Microcephaly Reduction of head (skull and brain) size. Usually, cases in which head circumference is
at least two standard deviations smaller than the gestational age and body size average
are considered microcephalic. In CZS cases, a collapsed skull with overlapping sutures,
preeminent occiput, and marked craniofacial disproportion are observed.
Calcifications Abnormal calcium deposits. These can be diagnosed via computed tomography or
magnetic resonance imaging. In CZS, subcortical calcifications are usually observed,
while in other STORCH infections, periventricular calcifications are more common.
Ventriculomegaly Abnormal dilatation of lateral ventricles.
Lissencephaly Cortical surface is abnormally smoothed. It is usually accompanied by defects of
gyrification.
Corpus callosum
abnormalities
Hypoplasia, dysgenesis, and agenesis of the corpus callosum are reported.
Eye abnormalities Macular scarring and focal pigment retinal mottling are some of the most frequent
characteristics.
Other disorders Hypertonia, extrapyramidal signs, and congenital contractures in the limbs.
Abbreviations: CZS, Congenital Zika Syndrome; STORCH, Syphilis, Toxoplasmosis, others, Rubella,
Cytomegalovirus, and Herpes virus.
https://doi.org/10.1371/journal.pbio.2006592.t001
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contemporary Americas strains produce stronger effects on mouse brain development, both
when infected prenatally and in newborns, than ancestral ones. The Americas ZIKV replicates
at higher rates in the brain and disturbs cell proliferation and differentiation much more than
the ancestral Asian ZIKV. According to their analyses, a single mutation, which occurred
immediately before the outbreak in French Polynesia, is responsible for the differential neuro-
virulent effect [12]. This mutation largely coincided with the first reports linking ZIKV to neu-
rological abnormalities, such as the Guillain–Barre´ syndrome, in 2013. The specifics with
respect to how exactly ZIKV lineages differentiate themselves regarding their virulence and
their impact on neural development is still under debate.
Evolutionary changes in ZIKV genome that facilitated the rapid geographic dispersion
from Asia to the Americas and subsequently within the Americas should also be addressed.
Some reports have stated that there were viral adaptations that enhanced the infectivity, both
in human and mosquitoes [21–23]. These changes may explain the magnitude of the most
recent Asian and Americas outbreaks, which are unprecedented in ZIKV history. In fact, it
could be argued that the neurotropic effects of ZIKV were neglected prior to recent outbreaks,
since former African and Asian epidemics infected fewer people in absolute terms, thus limit-
ing visibility on patterns of congenital malformations substantially. Worth noting is the fact
that infection with ZIKV provides immunity against posterior inoculation [24], and thus the
impact of this virus now in the Americas could be related to large immunologically naive pop-
ulations not previously exposed.
Altogether, viral genetic evidence of ZIKV’s evolution provides possible explanations on
why CZS has been observed now but not in prior outbreaks outside the Americas. However,
the scientific community remains unable to explain the high concentration of CZS in Brazil,
especially the high concentration in its Northeast region. As such, focus has shifted beyond the
virus itself to the examination of potential cofactors.
Genetic and environmental cofactors
The impact of infectious diseases on human populations is variable and subject to population-
and environmental-specific factors. Both of which potentially support the observed geographic
clustering of CZS in Brazil.
Since immunodeficiency is at least in part inherited, a population’s genetic background
modulates infection susceptibility. Regarding viral diseases, there are many examples in which
the outcome of an infection depends on the genetic composition of the host. Susceptibility to
Fig 1. Geographical distribution of CZS. (A) Countries that have reported microcephaly and CNS malformation
cases potentially associated with ZIKV infection until the end of 2016 according to WHO. Colors indicate the number
of cases reported. (B) In Brazil (2015–2016), the prevalence of infection-related microcephaly varies according to the
region. Here, the values for the rate between cases of ZIKV-related microcephaly and cases of ZIKV infection during
pregnancy is displayed. Data was obtained from [19]. In the Northeast region, the amount of cases was relatively high
(approximately 1,300 ZIKV-related microcephaly per 10,000 infected pregnants), while the Southeast region, for
instance, showed lower prevalence (approximately 145 ZIKV-related microcephaly per 10,000 infected pregnants). (C)
Distribution of average income per capita in each region of Brazil as informed by [37] for 2015. The lowest values
correspond to the Northeast region. CNS, central nervous system; CZS, Congenital Zika Syndrome; ZIKV, Zika virus.
https://doi.org/10.1371/journal.pbio.2006592.g001
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human papillomaviruses (HPV) was partially understood when a genome linkage study
showed that recessive mutations in two specific genes (EVER1 and EVER2) were associated
with the occurrence of cases of Epidermodysplasia verruciformis, a disease in which patients
showed severe symptoms provoked by HPV and developed skin cancer [25]. In other words,
people who have these mutations are more sensitive to HPV infection and consequently
develop this rare disease. Another example is influenza virus, which manifests itself as a flu in
around 10%–25% of the world’s population every year. The consequences of influenza infec-
tions vary from asymptomatic cases to death. Quantitative genetic studies on family pedigrees
have shown that death caused by influenza is recurrent among relatives, suggesting that there
is heritable predisposition to produce an insufficient immune response to this virus [26].
Animal models that have been used to experimentally reproduce physiopathological condi-
tions related to ZIKV support the idea that the genetic background is relevant to infection. For
example, in vivo experiments have demonstrated that adult wild-type mice, in contrast to type I
IFN (Ifnar1) deficient mice, do not transfer ZIKV via the placenta efficiently. Approaches in
which Ifnar1, a pathway response against viral infection [27,28], is disrupted, either through the
administration of a blocking antibody [29–31] or the use of Ifnar1 knocked-out mice
[28,30,32,33], are a suitable CZS model. In general, blocking Ifnar1 pathway before ZIKV infec-
tion leads to an increased viral load and a more compromised phenotype [28,30]. As such, genet-
ics, as observed in mouse models, could be shaping the ZIKV effects in human populations.
Recently, the first systematic study of twins with CZS shed some light on the role of genetics
[34]. According to its results, monozygotic twins, who were exposed to ZIKV during preg-
nancy, are both more prone to display CZS (concordant) than the pair of dizygotic twins, who
are more likely to be discordant (one of the pair affected and the other one not). When analyz-
ing gene expression of neural progenitor cells of discordant dizygotic twins, the study found
that cells derived from those babies affected by CZS displayed a differential signature in neural
development genes. This could explain, at least in part, the susceptibility of these cases to
ZIKV infection [34]. Along these lines, analyses on differential gene expression could give
important clues to formulate hypotheses regarding the role of genetics in CZS. In Table 2, we
provide a summary of genes that have been found to be deregulated upon ZIKV infection.
Interestingly, most of these genes identified as down-regulated after ZIKV infection have a
robust expression in the embryonic neurogenic regions (Fig 2). However, it remains unan-
swered whether the ability of a pregnant woman to unfold a robust immune reaction to ZIKV
infection and to prevent vertical transmission is explained by genetic background.
In addition to genetic background, environmental context can be a factor that impacts the
immune status and response to ZIKV infection. In human populations, environmental factors
that impact immune status are strongly related to socioeconomic position. Housing condi-
tions, malnutrition, and coinfection susceptibility amongst other variables differ by region as
well as by population and may contribute to differing responses to ZIKV infection.
Table 2. Deregulated genes from representative biological processes upon ZIKV infection, verified in vitro and in vivo studies.
Biological Process Genes Expression References
Antiviral response Mx1, Isg15, Off7, Oas2, Ifah1, Ddx58,Tlr2, Ddx6, eIF3c, DGCR8, IL17Ra Up-regulated [35–37]
Potential ZIKV entry receptors Axl Up-regulated [35]
Cell cycle Casc5, Rbbp8, Cdk6, Ccne2 Down-regulated [35–37]
Neural development Mcph1, Tbr2, Aspm, NeuroD1, Satb2, Cenpj, FoxG1, Lhx2 Down-regulated [34–37]
Abbreviation: ZIKV, Zika virus.
https://doi.org/10.1371/journal.pbio.2006592.t002
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As previously stated, the most affected area of Brazil regarding occurrences of CZS is the
Northeast. Socioeconomic indicators reveal that this region has the lowest per capita average
income in Brazil—amounting to around US$240 per month versus around US$450 in the
Central-West [38] (Fig 1C). The dispersion is also reflected in more comprehensive parame-
ters of social development, such as the Human Development Index (HDI), of which munici-
palities of the Northeast region have amongst the lowest scores in the country [39].
Epidemiological surveys tie demographic parameters to the prevalence of ZIKV congenital
syndrome CZS [20,40]. When analyzing this relationship for Recife (Pernambuco), a city that
was severely affected, it was found that cases of reported microcephaly in 2015 and 2016 were
largely concentrated in areas with more impoverished living conditions [20]. In general,
Fig 2. Gene expression is depicted using in situ hybridization in mouse samples of embryonic day (E15). Pictures were obtained from the open site
GenePaint (http://www.GenePaint.org).
https://doi.org/10.1371/journal.pbio.2006592.g002
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communities with lower socioeconomic status have more degraded housing, which facilitates
ZIKV transmission by enabling mosquito’s easier reproduction and human access. In fact,
dengue virus (DENV) prevalence in the same area of Brazil has been found to be strongly
related to living conditions [41]. Although this ecological vector-based hypothesis provides a
fertile area for further study and could describe a potential increase in infection cases, it may
fall short of explaining why geographic regions characterized by similar levels of ZIKV infec-
tion and pregnancy are impacted differently by CZS. Two other hypotheses, which associated
the CZS epidemic with the use of the larvicide pyriproxyfen or vaccine administration during
pregnancy (Tdap) were dismissed by a recent case-control study in Recife [40].
Coinfections with other flaviviruses transmitted by the same vector (Aedes mosquito) could
play a role in the immune response to ZIKV infection. DENV, for example, is endemic in
South America, and its seroprevalence is found in more than 90% of the population within
CSZ cluster regions [42]. It is known that after initial infection with DENV, posterior expo-
sures to other DENV serotypes could result in life-threatening complications due to the phe-
nomenon known as antibody-dependent enhancement. This describes a process in which
antibodies generated during the first infection bind to the new virus but fail to efficiently neu-
tralize it. Instead, the phenomenon facilitates virus entry to target cells.
Since ZIKV is structurally close to DENV, several studies have examined their cross-reactiv-
ity [43,44]. The studies demonstrated that antibodies generated after initial DENV infection
bind with high levels of affinity to ZIKV and significantly enhance pathogenesis but ultimately
fail to counteract the virus. The mechanism for this viral enhancement is thought to be medi-
ated by immunoglobulin G engagement of Fc gamma receptors (FcyR), in agreement with
other antibody-dependent enhancement examples [45].
Nutrition is an additional cofactor tied to both socioeconomic and demographic condi-
tions, which is positively correlated with income as well as development levels and has been
demonstrated to interfere with immunity. Malnutrition due to the insufficient intake of nutri-
ents leads to impairment of immune function for several innate and adaptive pathways [46–
49]. Further studies may explore the link between these specific cofactors and cases of birth
defects produced after ZIKV infection.
Missing gaps
Several aspects of ZIKV expansion and CZS prevalence can be obscured by confounding fac-
tors. First, the estimated number of infected patients is probably under-reported since a large
proportion of infected individuals remain asymptomatic or with very mild and unspecific
symptoms that could even be unnoticed. In fact, it is feasible that in previous ZIKV outbreaks,
the relation between the infection and neurological diseases remained obscured by this under-
estimation of ZIKV infected cases. Second, the diagnosis for microcephaly is complicated
because determination should be made based on the measure of head circumference with ref-
erence to age, sex, and body size. The latter point could be a problem since one of the features
described in many cases of CZS is intrauterine growth restriction, which leads to a general
reduction in body size/weight. Intrauterine growth restriction (IUGR) is a condition that is
more frequent in vulnerable sectors of the society and in developing nations. It is broadly
known that in cases of IUGR, brain size is relatively spared because its growth is preserved at
expense of other tissues and organs [50]. Since the definition of microcephaly depends on
body size, those children with lower body weight are expected to have even lower head circum-
ference to be considered as a case of microcephaly. In this sense, many of those microcephalic
cases found in Northeast Brazil during ZIKV outbreaks would be more extreme and probably
more “noticeable.” This aspect could be considered one of the factors that contribute to
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overestimate CZS in lower socioeconomic classes. However, higher social classes have more
access to private health services and more personalized care. Diagnosis of microcephaly would
be accurate and careful in most of the cases in which body weight is normal. Therefore, the
definition of microcephaly in CZS can be biased by these methodological and socioeconomic
aspects as well. Further, immunological tests are still subjected to cross-reaction with other fla-
viviruses, interfering with an accurate diagnosis of viral infection. All these points complicate
an estimation of the number of infected people in epidemiological studies.
Another important point that could bias epidemiological studies on CZS distribution is the
differential access to reproductive health [51–53]. According to recent reports, after the mas-
sive publicity on the potential risks of congenital infection, Brazil observed a decline in the
number of births. Since the number of fetal deaths did not change, this shift could be caused
by a combination of postponement and pregnancy interruption [51]. By early 2016, health
authorities from different Latin American countries recommended to postpone pregnancies to
reduce the potential risk of CZS. However, in this region, more than half of pregnancies are
unintended [54], revealing that this kind of recommendation likely only had a limited impact
as a public health measure. Safe methods of contraception and abortion are not equally accessi-
ble for different socioeconomic cohorts. Regarding abortion, as it is an illegal practice in most
Latin American countries, there is no reliable information on the actual number of cases. Fur-
ther, abortion as well as pregnancy interruption for economic reasons is still a culturally stig-
matized action [55]. Nevertheless, it has been reported that requests for information on
abortion through Women on Web, an organization that provides access to mifepristone and
misoprostol (two abortion medications), have significantly increased in those Latin American
countries with large number of autochthonous ZIKV cases. In Brazil in particular, requests
between November 2015 and March 2016 increased by 108% [56].
Finally, a recent experimental work on mice has demonstrated that the route of inoculation
influences the rate of infection as well as the viral load found in the developing embryos.
According to this study, sexual transmission results in more cases of infected embryos, reflect-
ing that this route leads to more frequent vertical infection [57]. We can thus speculate that in
social sectors with fragile reproductive health and prophylaxis, this route of infection would
have a disproportionate impact. More population-based studies are necessary to properly test
the hypothesis that there are differences in the prevalence of the infection route along popula-
tions and how this influences the distribution of CZS cases.
An interdisciplinary challenge
The recent ZIKV outbreak created a long-term burden for affected nations with social and
economic consequences that still cannot be fully quantified. The global biomedical research
reaction to understand CZS, however, was remarkable. From these coordinated efforts, the
necessity to strengthen and support epidemiological surveillance, which can not only help
direct prevention but also provide information of scientific value for the future, became evi-
dent. ZIKV infection numbers dropped dramatically, and CZS patients born in 2017 are
almost inexistent in South America [19]. A plausible explanation for this pattern may be the
immunization of the vast majority of the at-risk population [23]. However, specific serological
analyses remain necessary to confirm this.
In conclusion, ZIKV provides an example of how important constant dialogue between
experimental, epidemiological, and viral vigilance work is. After ZIKV emerged as a medical
concern at the end of 2015, answers to many questions came from the collaborative work of
virologists, immunologists, epidemiologists, geneticists, neuroscientists, and developmental
biologists, among others. To better understand why CZS is nonhomogeneously distributed
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among human populations, more interdisciplinary studies are needed. Future advances in
understanding the role of cofactors in CZS should result from these interdisciplinary efforts.
Author Contributions
Conceptualization: Jimena Barbeito-Andre´s, Patricia Pestana Garcez.
Funding acquisition: Lavı´nia Schuler-Faccini, Patricia Pestana Garcez.
Investigation: Jimena Barbeito-Andre´s.
Writing – original draft: Jimena Barbeito-Andre´s, Patricia Pestana Garcez.
Writing – review & editing: Jimena Barbeito-Andre´s, Lavı´nia Schuler-Faccini, Patricia Pes-
tana Garcez.
References
1. Dick GWA, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc
Trop Med Hyg. 1952; 46: 509–20. https://doi.org/10.1016/0035-9203(52)90042-4 PMID: 12995440
2. Mac Namara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice
in Nigeria. Trans R Soc Trop Med Hyg. 1954; 48: 139–45. https://doi.org/10.1016/0035-9203(54)
90006-1 PMID: 13157159
3. Hayes EB. Zika Virus Outside Africa. Emerg Infect Dis. 2009; 15: 1347–1350. https://doi.org/10.3201/
eid1509.090442 PMID: 19788800
4. Simonin Y, van Riel D, Van de Perre P, Rockx B, Salinas S. Differential virulence between Asian and
African lineages of Zika virus. Rico-Hesse R, editor. PLoS Negl Trop Dis. 2017; 11: e0005821. https://
doi.org/10.1371/journal.pntd.0005821 PMID: 28934211
5. Tang H, Hammack C, Ogden SC, Wen Z, Qian X, Li Y, et al. Zika Virus Infects Human Cortical Neural
Progenitors and Attenuates Their Growth. Cell Stem Cell. 2016; 18: 587–590. https://doi.org/10.1016/j.
stem.2016.02.016 PMID: 26952870
6. Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R, et al. Zika virus impairs
growth in human neurospheres and brain organoids. Science (80-). 2016; 352: 816–818. https://doi.org/
10.1126/science.aaf6116 PMID: 27064148
7. Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JLM, Guimarães KP, et al. The Brazilian Zika
virus strain causes birth defects in experimental models. Nature. Nature Publishing Group; 2016; 1–15.
https://doi.org/10.1038/nature18296 PMID: 27279226
8. Coyne CB, Lazear HM. Zika virus—reigniting the TORCH. Nat Rev Microbiol. 2016; 14: 707–715.
https://doi.org/10.1038/nrmicro.2016.125 PMID: 27573577
9. Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura C V., Fonseca EB da, et al. Characterizing the
Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr. 2017; 171:
288. https://doi.org/10.1001/jamapediatrics.2016.3982 PMID: 27812690
10. del Campo M, Feitosa IML, Ribeiro EM, Horovitz DDG, Pessoa ALS, Franc¸a GVA, et al. The phenotypic
spectrum of congenital Zika syndrome. Am J Med Genet Part A. 2017; 173: 841–857. https://doi.org/10.
1002/ajmg.a.38170 PMID: 28328129
11. Chimelli L, Melo ASO, Avvad-Portari E, Wiley CA, Camacho AHS, Lopes VS, et al. The spectrum of
neuropathological changes associated with congenital Zika virus infection. Acta Neuropathol. 2017;
133: 983–999. https://doi.org/10.1007/s00401-017-1699-5 PMID: 28332092
12. Yuan L, Huang X-Y, Liu Z-Y, Zhang F, Zhu X-L, Yu J-Y, et al. A single mutation in the prM protein of
Zika virus contributes to fetal microcephaly. Science (80-). 2017; 358: 933–936. https://doi.org/10.1126/
science.aam7120 PMID: 28971967
13. Metsky HC, Matranga CB, Wohl S, Schaffner SF, Freije CA, Winnicki SM, et al. Zika virus evolution and
spread in the Americas. Nature. 2017; 546: 411–415. https://doi.org/10.1038/nature22402 PMID:
28538734
14. Faria NR, Azevedo R d. S d. S, Kraemer MUG, Souza R, Cunha MS, Hill SC, et al. Zika virus in the
Americas: Early epidemiological and genetic findings. Science (80-). 2016; 352: 345–349. https://doi.
org/10.1126/science.aaf5036 PMID: 27013429
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006592 August 24, 2018 8 / 11
15. Kraemer MUG, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, et al. The global compendium of
Aedes aegypti and Ae. albopictus occurrence. Sci Data. 2015; 2: 150035. https://doi.org/10.1038/
sdata.2015.35 PMID: 26175912
16. Chouin-Carneiro T, Vega-Rua A, Vazeille M, Yebakima A, Girod R, Goindin D, et al. Differential Sus-
ceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika Virus. Turell MJ, editor.
PLoS Negl Trop Dis. 2016; 10: e0004543. https://doi.org/10.1371/journal.pntd.0004543 PMID:
26938868
17. D’Ortenzio E, Matheron S, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, et al. Evidence of
Sexual Transmission of Zika Virus. N Engl J Med. 2016; 374: 2195–2198. https://doi.org/10.1056/
NEJMc1604449 PMID: 27074370
18. Mansuy JM, Suberbielle E, Chapuy-Regaud S, Mengelle C, Bujan L, Marchou B, et al. Zika virus in
semen and spermatozoa. Lancet Infect Dis. 2016; 16: 1106–1107. https://doi.org/10.1016/S1473-3099
(16)30336-X PMID: 27676340
19. de Oliveira WK, de Franc¸a GVA, Carmo EH, Duncan BB, de Souza Kuchenbecker R, Schmidt MI. Infec-
tion-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based
analysis. Lancet. 2017; 390: 861–870. https://doi.org/10.1016/S0140-6736(17)31368-5 PMID:
28647172
20. Souza WV de, Albuquerque M de FPM de, Vazquez E, Bezerra LCA, Mendes A da CG, Lyra TM, et al.
Microcephaly epidemic related to the Zika virus and living conditions in Recife, Northeast Brazil. BMC
Public Health. 2018; 18: 130. https://doi.org/10.1186/s12889-018-5039-z PMID: 29329574
21. Delatorre E, Mir D, Bello G. Tracing the origin of the NS1 A188V substitution responsible for recent
enhancement of Zika virus Asian genotype infectivity. Mem Inst Oswaldo Cruz. 2017; 112: 793–795.
https://doi.org/10.1590/0074-02760170299 PMID: 28876359
22. Liu Y, Liu J, Du S, Shan C, Nie K, Zhang R, et al. Evolutionary enhancement of Zika virus infectivity in
Aedes aegypti mosquitoes. Nature. 2017; 545: 482–486. https://doi.org/10.1038/nature22365 PMID:
28514450
23. Xia H, Luo H, Shan C, Muruato AE, Nunes BTD, Medeiros DBA, et al. An evolutionary NS1 mutation
enhances Zika virus evasion of host interferon induction. Nat Commun. 2018; 9: 414. https://doi.org/10.
1038/s41467-017-02816-2 PMID: 29379028
24. Osuna CE, Lim S, Deleage C, Griffin BD, Stein D, Schroeder LT, et al. Zika viral dynamics and shedding
in rhesus and cynomolgus macaques. Nat Med. Nature Publishing Group; 2016; 1–10. https://doi.org/
10.1038/nm.4033 PMID: 26735395
25. Ramoz N, Rueda L-A, Bouadjar B, Montoya L-S, Orth G, Favre M. Mutations in two adjacent novel
genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002; 32: 579–81. https://doi.
org/10.1038/ng1044 PMID: 12426567
26. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a Heritable Predispo-
sition to Death Due to Influenza. J Infect Dis. 2008; 197: 18–24. https://doi.org/10.1086/524064 PMID:
18171280
27. Chen J, Liang Y, Yi P, Xu L, Hawkins HK, Rossi SL, et al. Outcomes of Congenital Zika Disease Depend
on Timing of Infection and Maternal-Fetal Interferon Action. Cell Rep. 2017; 21: 1588–1599. https://doi.
org/10.1016/j.celrep.2017.10.059 PMID: 29117563
28. Yockey LJ, Jurado KA, Arora N, Millet A, Rakib T, Milano KM, et al. Type I interferons instigate fetal
demise after Zika virus infection. Sci Immunol. 2018; 3: eaao1680. https://doi.org/10.1126/sciimmunol.
aao1680 PMID: 29305462
29. Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, Miner JJ, et al. A Mouse Model of Zika Virus
Pathogenesis Cell Host & Microbe Resource A Mouse Model of Zika Virus Pathogenesis. Cell Host
Microbe. Elsevier Inc.; 2016; 19: 1–11. https://doi.org/10.1016/j.chom.2015.12.012 PMID: 26764588
30. Miner JJ, Cao B, Govero J, Smith AM, Fernandez E, Cabrera OH, et al. Zika Virus Infection during Preg-
nancy in Mice Causes Placental Damage and Fetal Demise. Cell. Elsevier Inc.; 2016; 165: 1–11.
https://doi.org/10.1016/j.cell.2016.05.008 PMID: 27180225
31. Cao B, Diamond MS, Mysorekar IU. Maternal-Fetal Transmission of Zika Virus: Routes and Signals for
Infection. J Interf Cytokine Res. 2017; 37: 287–294. https://doi.org/10.1089/jir.2017.0011 PMID:
28402153
32. Sapparapu G, Fernandez E, Kose N, Bin Cao, Fox JM, Bombardi RG, et al. Neutralizing human anti-
bodies prevent Zika virus replication and fetal disease in mice. Nature. 2016; 540: 443–447. https://doi.
org/10.1038/nature20564 PMID: 27819683
33. Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, Miner JJ, et al. A Mouse Model of Zika Virus
Pathogenesis. Cell Host Microbe. 2016; 19: 720–730. https://doi.org/10.1016/j.chom.2016.03.010
PMID: 27066744
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006592 August 24, 2018 9 / 11
34. Caires-Ju´nior LC, Goulart E, Melo US, Araujo BSH, Alvizi L, Soares-Schanoski A, et al. Discordant con-
genital Zika syndrome twins show differential in vitro viral susceptibility of neural progenitor cells. Nat
Commun. 2018; 9: 475. https://doi.org/10.1038/s41467-017-02790-9 PMID: 29396410
35. Li C, Xu D, Ye Q, Hong S, Jiang Y, Liu X, et al. Zika Virus Disrupts Neural Progenitor Development and
Leads to Microcephaly in Mice. Cell Stem Cell. 2016; 19: 672. https://doi.org/10.1016/j.stem.2016.10.
017 PMID: 27814481
36. Garcez PP, Nascimento JM, de Vasconcelos JM, Madeiro da Costa R, Delvecchio R, Trindade P, et al.
Zika virus disrupts molecular fingerprinting of human neurospheres. Sci Rep. 2017; 7: 40780. https://
doi.org/10.1038/srep40780 PMID: 28112162
37. Wu K-Y, Zuo G-L, Li X-F, Ye Q, Deng Y-Q, Huang X-Y, et al. Vertical transmission of Zika virus targeting
the radial glial cells affects cortex development of offspring mice. Cell Res. 2016; 26: 645–654. https://
doi.org/10.1038/cr.2016.58 PMID: 27174054
38. Instituto Brasileiro de Geografia e Estatı´stica. Indicadores Sociais da populac¸ão brasileira. Rio de
Janeiro: Gerência de Biblioteca e Acervos Especiais; 2015. Available from: https://www.ibge.gov.br/
39. Atlas do Desenvolvimento Humano no Brasil [Internet]. 2015. Available from: http://atlasbrasil.org.br
40. de Arau´jo TVB, Ximenes RA de A, Miranda-Filho D de B, Souza WV, Montarroyos UR, de Melo APL,
et al. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report
of a case-control study. Lancet Infect Dis. 2017; https://doi.org/10.1016/S1473-3099(17)30727-2
41. Braga C, Luna CF, Martelli CM, Souza WV de, Cordeiro MT, Alexander N, et al. Seroprevalence and
risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop. 2010;
113: 234–240. https://doi.org/10.1016/j.actatropica.2009.10.021 PMID: 19896921
42. Castanha PM da S, Cordeiro MT, Martelli CMT, Souza WV, Marques ETA, Braga C. Force of infection
of dengue serotypes in a population-based study in the northeast of Brazil. Epidemiol Infect. 2013; 141:
1080–1088. https://doi.org/10.1017/S0950268812001367 PMID: 22800513
43. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-spaeth G, Duangchinda T, et al. Dengue
virus sero-cross-reactivity drives antibody- dependent enhancement of infection with zika virus. Nat
Publ Gr. Nature Publishing Group; 2016; 17: 1102–1108. https://doi.org/10.1038/ni.3515 PMID:
27339099
44. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J. Human antibody responses after
dengue virus infection are highly cross-reactive to Zika virus. 2016; 113. https://doi.org/10.1073/pnas.
1607931113 PMID: 27354515
45. Bardina SV., Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, et al. Enhancement of Zika virus patho-
genesis by preexisting antiflavivirus immunity. Science (80-). 2017; 356: 175–180. https://doi.org/10.
1126/science.aal4365 PMID: 28360135
46. Revillard JP, Cozon G. Experimental models and mechanisms of immune deficiencies of nutritional ori-
gin. Food Addit Contam. 1990; 7: S82–S86. https://doi.org/10.1080/02652039009373853 PMID:
2124553
47. Chandra RK. Nutrition and immunoregulation. Significance for host resistance to tumors and infectious
diseases in humans and rodents. J Nutr. 1992; 122: 754–7. https://doi.org/10.1093/jn/122.suppl_3.754
PMID: 1542043
48. Losada-Barraga´n M, Umaña-Pe´rez A, Cuervo-Escobar S, Berbert LR, Porrozzi R, Morgado FN, et al.
Protein malnutrition promotes dysregulation of molecules involved in T cell migration in the thymus of
mice infected with Leishmania infantum. Sci Rep. 2017; 7: 45991. https://doi.org/10.1038/srep45991
PMID: 28397794
49. Naylor C, Petri WA. Leptin Regulation of Immune Responses. Trends Mol Med. 2016; 22: 88–98.
https://doi.org/10.1016/j.molmed.2015.12.001 PMID: 26776093
50. Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neu-
rodevelopmental outcome. J Physiol. 2016; 594: 807–823. https://doi.org/10.1113/JP271402 PMID:
26607046
51. Castro MC, Han QC, Carvalho LR, Victora CG, Franc¸a GVA. Implications of Zika virus and congenital
Zika syndrome for the number of live births in Brazil. Proc Natl Acad Sci U S A. 2018; 201718476.
https://doi.org/10.1073/pnas.1718476115 PMID: 29844186
52. Gonza´lez Ve´lez AC, Diniz SG. Inequality, Zika epidemics, and the lack of reproductive rights in Latin
America. Reprod Health Matters. 2016; 24: 57–61. https://doi.org/10.1016/j.rhm.2016.11.008 PMID:
28024678
53. Harris LH, Silverman NS, Marshall MF. The Paradigm of the Paradox: Women, Pregnant Women, and
the Unequal Burdens of the Zika Virus Pandemic. Am J Bioeth. 2016; 16: 1–4. https://doi.org/10.1080/
15265161.2016.1177367 PMID: 27111356
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006592 August 24, 2018 10 / 11
54. Sedgh G, Singh S, Hussain R. Intended and Unintended Pregnancies Worldwide in 2012 and Recent
Trends. Stud Fam Plann. 2014; 45: 301–314. https://doi.org/10.1111/j.1728-4465.2014.00393.x PMID:
25207494
55. Roa M. Zika virus outbreak: Reproductive health and rights in Latin America. Lancet. 2016; 387: 843.
https://doi.org/10.1016/S0140-6736(16)00331-7
56. Aiken ARA, Scott JG, Gomperts R, Trussell J, Worrell M, Aiken CE. Requests for Abortion in Latin
America Related to Concern about Zika Virus Exposure. N Engl J Med. 2016; 375: 396–398. https://doi.
org/10.1056/NEJMc1605389 PMID: 27331661
57. Duggal NK, McDonald EM, Ritter JM, Brault AC. Sexual transmission of Zika virus enhances in utero
transmission in a mouse model. Sci Rep. Springer US; 2018; 8: 1–8. https://doi.org/10.1038/s41598-
017-17765-5 PMID: 29311619
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006592 August 24, 2018 11 / 11
